The In-Orbit Battery Reconditioning Experience On Board the Orion 1 Spacecraft

The Orion 1 spacecraft is a three-axis stabilized geostationary earth orbiting commercial communications satellite which was launched on November 29, 1994 aboard an Atlas II launch vehicle. The power subsystem is a dual bus, dual battery semi-regulated system with one 78 Ampere-hour nickel-hydrogen battery per bus. The batteries were built and tested by Eagle Picher Industries, Inc., of Joplin, MO and were integrated into the spacecraft by its manufacturer, Matra Marconi Space UK Ltd. This paper presents the results obtained during the first four in-orbit reconditioning cycles and compares the battery performance to ground test data. In addition, the on-station battery management strategy and implementation constraints are described. Battery performance has been nominal throughout each reconditioning cycle and subsequent eclipse season

Distinct Levels of Sox9 Expression Mark Colon Epithelial Stem Cells that Form Colonoids in Culture

Sox9 is an high-mobility group box transcription factor that is expressed in the stem cell zone of the small intestine and colon. We have previously used a Sox9EGFP mouse model to demonstrate that discrete levels of Sox9 expression mark small intestine epithelial stem cells that form crypt/villus-like structures in a three-dimensional culture system (Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. Am J Physiol Gastrointest Liver Physiol 296: G1108–G1118, 2009; Gracz AD, Ramalingam S, Magness ST. Am J Physiol Gastrointest Liver Physiol 298: G590–G600, 2010). In the present study, we hypothesized that discrete levels of Sox9 expression would also mark colonic epithelial stem cells (CESCs). Using the Sox9EGFP mouse model, we show that lower levels of Sox9 mark cells in the transit-amplifying progenitor cell zone, while higher levels of Sox9 mark cells in the colonic crypt base. Furthermore, we demonstrate that variable SOX9 levels persist in cells of colonic adenomas from mice and humans. Cells expressing lower Sox9 levels demonstrate gene expression profiles consistent with more differentiated populations, and cells expressing higher Sox9 levels are consistent with less differentiated populations. When placed in culture, cells expressing the highest levels of Sox9 formed “colonoids,” which are defined as bodies of cultured colonic epithelial cells that possess multiple cryptlike structures and a pseudolumen. Cells expressing the highest levels of Sox9 also demonstrate multipotency and self-renewal in vitro, indicating functional stemness. These data suggest a dose-dependent role for Sox9 in normal CESCs and cells comprising colon tumors. Furthermore, distinct Sox9 levels represent a new biomarker to study CESC and progenitor biology in physiological and disease states